07.02.2013 15:20 Uhr, Quelle: Wallstreet online

´New Technologies to Capture Over 10% of the Antibody Therapeutics Market by 2023´ Shows Visiongain Report

LONDON, February 7, 2013 /PRNewswire/ A new report by Visiongain [http://www.visiongain.com ] shows that next-generation technologies will become a major driver for the antibody therapeutics market [http://www.visiongain.com/Sector/8/Pharma ]. …

Weiterlesen bei Wallstreet online